Crossmark

The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-018-3168-4

Published Online: 2019-01-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Niezgoda, Anna https://orcid.org/0000-0002-8189-7520
Winnicki, Andrzej

Kosmalski, Tomasz

Kowaliszyn, Bogna

Krysiński, Jerzy

Czajkowski, Rafał
License Information

Text and Data Mining valid from 2019-01-25
More Information

Article History

Received: 11 March 2018

Accepted: 30 December 2018

First Online: 25 January 2019

Ethics approval and consent to participate

: The study protocol has been approved by The Ethics Committee of Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz (approval number KB 597/2016). All study-related procedures can be performed only after obtaining written informed consent from the participants.

: Consent for publication is not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below